David Demartino

David has more than 20 years of experience in healthcare asset management, equity research, and investment banking. David held senior analyst positions at Velan Capital, Citadel, and Pura Vida Investments, covering the medical devices, biotechnology, and healthcare technology industries. In addition to investing in publicly traded companies at Pura Vida, he worked on private company investments. David spent several years in sellside equity research, initially covering healthcare facilities at Deutsche Bank and then medical devices at Credit Suisse. He received his B.A. in Economics from Washington and Lee University.